Hangzhou Sumgen Biotech Co., Ltd.

This early-stage trial tests a new drug called SG301 in 61 people with blood cancers like multiple myeloma that have returned or stopped responding to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it helps control the cancer. P…

This early-stage study tests a new drug called SG2918 in 17 people with advanced cancers that have not responded to standard treatments. The main goal is to check if the drug is safe and tolerable, and to see early signs of whether it can help control the disease. Participants re…

This study is an early test of an experimental drug called SG301, given as an injection under the skin. It will first be tested in 48 healthy adults to check safety, then in people with systemic lupus erythematosus (SLE), an autoimmune disease. The main goal is to see if the drug…